APOB and metabolic dysfunction-associated steatotic liver disease: Non-HDLc represents atherogenic lipoproteins such as LDLc, very low-density lipoproteins, and small dense LDL (apolipoprotein B) [6], and the non-HDLc/HDLc ratio was detected to perform better than LDLc, HDLc or non-HDLc in estimating arterial stiffness [3] and non-alcoholic fatty liver disease [5].